Résumé
This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.
This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.
This document is not intended
— to define experimental protocols or methods for calculating the value of tumor mutation burden,
— for the other biological species, and
— for the Sanger sequencing methods.
Prévisualiser
Prévisualiser cette norme sur notre Plateforme de consultation en ligne (OBP)
Informations générales
-
État actuel: PubliéeDate de publication: 2023-12Stade: Norme internationale publiée [60.60]
-
Edition: 1
-
Comité technique :ISO/TC 215/SC 1ICS :35.240.80
- RSS mises à jour
Cycle de vie
Vous avez une question?
Consulter notre FAQ
Service à la clientèle
+41 22 749 08 88
Horaires d’ouverture:
De lundi à vendredi - 09:00-12:00, 14:00-17:00 (UTC+1)